Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 3Neoplasms 3Motor Activity 3Pancreatic Neoplasms 2Overweight 2Obesity 2Malnutrition 2Lung Neoplasms 2Colorectal Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Taste Disorders 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Patient Compliance 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Metabolic Diseases 1Lymphoma 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Hypertension 1Hypercholesterolemia 1Heart Failure 1Heart Diseases 1Esophageal Neoplasms 1

Interventions

Paclitaxel 15Carboplatin 9liposomal doxorubicin 8Bevacizumab 8pembrolizumab 7Topotecan 6olaparib 4mirvetuximab soravtansine 4Nivolumab 4Cyclophosphamide 4niraparib 3fludarabine 3Gemcitabine 3Drug Therapy 3rucaparib 2ribociclib 2pegfilgrastim 2palbociclib 2oregovomab 2fludarabine phosphate 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Fulvestrant 2Cisplatin 2Blood Specimen Collection 21-dodecylpyridoxal 2trastuzumab deruxtecan 1sacituzumab govitecan 1isoquercitrin 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Nutrition Assessment × 1 year × Clear all
NCT01439659 2026-01-16

Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡